All
Vitamin D advice must weigh benefits, risks
March 10th 2016While low levels of vitamin D are linked with several diseases, ingesting too much vitamin D increases risks for other health conditions. In counseling patients on supplementation, one must take into consideration patient characteristics such as individual medical conditions and race.
Strategies for coping with a disruptive physician
March 9th 2016A disruptive physician isn’t necessarily aggressive in an obviously obnoxious way. The disruption may come from behaving in a way that interferes with others’ work, not communicating across specialties or teams, or failing to give or receive effective feedback. Here’s what you can do to avoid a disrespectful and non-professional environment.
Secukinumab approved for psoriatic arthritis and ankylosing spondylitis
February 15th 2016Novartis announced January 15 that the FDA has approved secukinumab (Cosentyx, Novartis) for psoriatic arthritis (PsA) and active ankylosing spondylitis. The announcement comes a year after the FDA’s approval for secukinumab for treatment of adults with moderate to severe psoriasis. The drug is the only IL-17A antagonist approved for all three indications. learn more